Identity
Other names: Central neurofibromatosis; Bilateral acoustic neurofibromatosis; Bilateral acoustic neurinoma; Bilateral acoustic schwannomas Inheritance: autosomal dominant with almost complete penetrance; frequency is 3/10 5 newborns; neomutation represent 50% of cases; variable expressivity from mild disease through life (Gardner type) to severe condition at young age (Wishart type: with more than 3 tumours).
Clinics
NF2 is an hamartoneoplastic syndrome; hamartomas are localized tissue proliferations with faulty differenciation and mixture of component tissues; they are heritable malformations that have a potential towards neoplasia.
Phenotype and clinics
Bilateral vestibular (8th cranial pair) schwannomas; other central or peripheral nerve schwannomas; meningiomas; ependymomas. Hearing loss (average age 20 yrs), tinnitus, imbalance, headache, cataract in 50%, facial paralysis. Café-au-lait spots and cutaneous and peripheral neurofibromas may be present, but far less extensively than in neurofibromatosis type 1. Neoplastic risk NF2 cases represent about 5 % of schwannomas and meningiomas (i.e. risk increased by 2000), appearing at the age of 20, while they are found in the general population at the age of 50 and over. Prognosis These tumours are usually benign, but their location within the central nervous system gives them a grave prognosis; patients with the Wishart severe form usually do not survive past 50 yrs.
Cytogenetics

Inborn condition
Normal.
Cancer cytogenetics
Chromosome 22 loss is very frequent both in sporadic and in NF2 schwannomas and meningiomas. Description: 590 or 595 amino acids; 66 kDa; domains: NH2 --membrane binding --a helix binding to actin of the cytoskeleton --COOH. Expression: in lung, kidney, ovary, breast, placenta, neuroblasts. Function: membrane-cytoskeleton anchor (as APC also appears to be); has characteristics of a tumour suppressor, as has been found in sporadic as well as NF2 induced schwannomas and meningiomas (accordingly to the Rb model). Homology ezrin, radixin, moesin, members of the erythrocytes band 4.1 family, especially so in the Nterm. Mutations Germinal: (inborn condition of NF2 patients): protein truncations due to various frameshift deletions or insertions or nonsense mutations; splice-site or missense mutations are also found; phenotypegenotype correlations are observed (i.e. that severe phenotypes are found in cases with protein truncations rather than those with amino acid substitution). Somatic: tumourigenesis in NF2 patients.
Genes involved and Proteins
